Obesity
Also known as: Obesity (Disorder) / BMI >30 kg/m2 / Obese / Overweight and obesity / Obese (finding) / Obesity, unspecified / Obesity [Ambiguous] / Adiposity (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00182 | Amphetamine | A CNS stimulant and sympathomimetic agent indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). |
| DB00865 | Benzphetamine | A sympathomimetic used to manage exogenous obesity short term. |
| DB01156 | Bupropion | A norepinephrine and dopamine reuptake inhibitor used in the treatment of major depressive disorder (MDD), seasonal affective disorder (SAD), and as an aid to smoking cessation. |
| DB11637 | Delamanid | An antibiotic used to treat multidrug resistant tuberculosis. |
| DB00472 | Fluoxetine | A selective serotonin reuptake inhibitor used to treat major depressive disorder, bulimia, OCD, premenstrual dysphoric disorder, panic disorder, and bipolar I. |
| DB14161 | Lecithin, soybean | A complex mixture of phospholipids; glycolipids; and triglycerides; with substantial amounts of phosphatidylcholines; phosphatidylethanolamines; and phosphatidylinositols, which are sometimes loosely termed as 1,2-diacyl-3-phosphocholines. Lecithin is a component of the cell... |
| DB04871 | Lorcaserin | A serotonin 2C receptor agonist used in conjunction with physical activity and calorie restriction for weight loss in obese patients with a body mass index (BMI) of 30 and above, and in overweight patients with weight-related comorbidities. |
| DB00704 | Naltrexone | A narcotic antagonist used in opioid overdose. |
| DB01083 | Orlistat | A reversible inhibitor of gastrointestinal lipases indicated for weight loss and weight maintenance. |
| DB00191 | Phentermine | A sympathomimetic anorectic agent used as a short-term adjunct therapy that is included in a regimen of weight reduction in cases of exogenous obesity. |
| DB11584 | Pipradrol | A central nervous stimulant ingredient in a product used to treat functional fatigue. |
| DB11700 | Setmelanotide | Setmelanotide is indicated to treat obesity caused by genetic POMC, PCSK1, or LEPR deficiencies or Bardet-Biedl syndrome. |
| DB01105 | Sibutramine | A norepinephrine, serotonin and dopamine reuptake inhibitor indicated to assist with weight loss in obesity. |
| DB01586 | Ursodeoxycholic acid | A bile acid used for the treatment of primary biliary cirrhosis (PBC). |